Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteogenesis imperfecta: changes in noncollagenous proteins in bone.

U Vetter1, L W Fisher, K P Mintz

  • 1National Institutes of Health, National Institute of Dental Research, Bone Research Branch, Bethesda, MD 20892.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|May 1, 1991
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterisation of ovine bone marrow-derived stromal cells (oBMSC) and evaluation of chondrogenically induced micro-pellets for cartilage tissue repair in vivo.

Stem cell research & therapy·2021
Same author

Overlapping functions of bone sialoprotein and pyrophosphate regulators in directing cementogenesis.

Bone·2017
Same author

Absence of APOL1 risk alleles in a remote living Australian Aboriginal group with high rates of CKD, hypertension, diabetes, and cardiovascular disease.

Kidney international·2017
Same author

Reevaluation of the diametral compression test for tablets using the flattened disc geometry.

International journal of pharmaceutics·2016
Same author

The conserved carboxyl domain of MorC, an inner membrane protein of Aggregatibacter actinomycetemcomitans, is essential for membrane function.

Molecular oral microbiology·2015
Same author

The cell envelope proteome of Aggregatibacter actinomycetemcomitans.

Molecular oral microbiology·2014

Osteogenesis imperfecta (OI) alters bone protein levels, with reduced osteonectin and elevated bone sialoprotein, osteocalcin, and alpha 2-HS glycoprotein, potentially impacting bone fragility.

Area of Science:

  • Biochemistry
  • Orthopedics
  • Genetics

Background:

  • Osteogenesis imperfecta (OI) is a group of genetic disorders characterized by bone fragility.
  • Noncollagenous proteins play crucial roles in bone mineralization and structural integrity.

Purpose of the Study:

  • To quantify specific noncollagenous proteins in the bone of patients with different types of osteogenesis imperfecta.
  • To investigate the relationship between altered protein concentrations and bone fragility in OI.

Main Methods:

  • Cortical bone extracts from OI patients (Types I-IV) and controls were analyzed.
  • Levels of osteonectin, bone sialoprotein, osteocalcin, decorin, and alpha 2-HS glycoprotein were measured.

Main Results:

Related Experiment Videos

  • Osteonectin was reduced in all OI patients, with the lowest levels in severe Type III OI.
  • Bone sialoprotein was elevated in OI patients, particularly Type IV.
  • Osteocalcin and alpha 2-HS glycoprotein concentrations were increased in all OI patients; decorin levels remained unchanged.

    • Conclusions:

    • Altered noncollagenous protein profiles in OI bone may contribute to increased fragility.
    • These changes could interfere with proper bone mineralization and tissue organization.